Previous studies have shown that the serum levels of adiponectin are reduced in NASH patients (31), and hypoadiponectinemia is negatively associated with steatosis and inflammation in NAFLD patients (32). Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.